Wiegmans A - Search Results

1

Prion protein scrapie and the normal cellular prion protein.

Atkinson CJ, Zhang K, Munn AL, Wiegmans A, Wei MQ. Atkinson CJ, et al. Among authors: wiegmans a. Prion. 2016;10(1):63-82. doi: 10.1080/19336896.2015.1110293. Prion. 2016. PMID: 26645475 Free PMC article. Review.

2

EGFR and Prion protein promote signaling via FOXO3a-KLF5 resulting in clinical resistance to platinum agents in colorectal cancer.

Atkinson CJ, Kawamata F, Liu C, Ham S, Győrffy B, Munn AL, Wei MQ, Möller A, Whitehall V, Wiegmans AP. Atkinson CJ, et al. Among authors: wiegmans ap. Mol Oncol. 2019 Apr;13(4):725-737. doi: 10.1002/1878-0261.12411. Epub 2019 Feb 8. Mol Oncol. 2019. PMID: 30478887 Free PMC article.

3

Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer.

Wiegmans AP, Saunus JM, Ham S, Lobb R, Kutasovic JR, Dalley AJ, Miranda M, Atkinson C, Foliaki ST, Ferguson K, Niland C, Johnstone CN, Lewis V, Collins SJ, Lakhani SR, Al-Ejeh F, Möller A. Wiegmans AP, et al. JCI Insight. 2019 Feb 26;5(6):e124092. doi: 10.1172/jci.insight.124092. JCI Insight. 2019. PMID: 30830863 Free PMC article.

4

Potential roles for prions and protein-only inheritance in cancer.

Antony H, Wiegmans AP, Wei MQ, Chernoff YO, Khanna KK, Munn AL. Antony H, et al. Among authors: wiegmans ap. Cancer Metastasis Rev. 2012 Jun;31(1-2):1-19. doi: 10.1007/s10555-011-9325-9. Cancer Metastasis Rev. 2012. PMID: 22138778 Free PMC article. Review.

5

Tracking metastatic breast cancer: the future of biology in biosensors.

Lim YC, Wiegmans AP. Lim YC, et al. Among authors: wiegmans ap. Med Oncol. 2016 Apr;33(4):36. doi: 10.1007/s12032-016-0748-6. Epub 2016 Mar 19. Med Oncol. 2016. PMID: 26995223 Review.

6

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer.

Al-Ejeh F, Miranda M, Shi W, Simpson PT, Song S, Vargas AC, Saunus JM, Smart CE, Mariasegaram M, Wiegmans AP, Chenevix-Trench G, Lakhani SR, Khanna KK. Al-Ejeh F, et al. Oncotarget. 2014 May 30;5(10):3145-58. doi: 10.18632/oncotarget.1865. Oncotarget. 2014. PMID: 24762669 Free PMC article.

7

Rad51 supports triple negative breast cancer metastasis.

Wiegmans AP, Al-Ejeh F, Chee N, Yap PY, Gorski JJ, Da Silva L, Bolderson E, Chenevix-Trench G, Anderson R, Simpson PT, Lakhani SR, Khanna KK. Wiegmans AP, et al. Oncotarget. 2014 May 30;5(10):3261-72. doi: 10.18632/oncotarget.1923. Oncotarget. 2014. PMID: 24811120 Free PMC article.

8

RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy.

Wiegmans AP, Miranda M, Wen SW, Al-Ejeh F, Möller A. Wiegmans AP, et al. Oncotarget. 2016 Sep 13;7(37):60087-60100. doi: 10.18632/oncotarget.11065. Oncotarget. 2016. PMID: 27507046 Free PMC article.

9

Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance.

Lobb RJ, van Amerongen R, Wiegmans A, Ham S, Larsen JE, Möller A. Lobb RJ, et al. Among authors: wiegmans a. Int J Cancer. 2017 Aug 1;141(3):614-620. doi: 10.1002/ijc.30752. Epub 2017 May 12. Int J Cancer. 2017. PMID: 28445609 Free article.

10

Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor.

Al-Ejeh F, Shi W, Miranda M, Simpson PT, Vargas AC, Song S, Wiegmans AP, Swarbrick A, Welm AL, Brown MP, Chenevix-Trench G, Lakhani SR, Khanna KK. Al-Ejeh F, et al. Among authors: wiegmans ap. J Nucl Med. 2013 Jun;54(6):913-21. doi: 10.2967/jnumed.112.111534. Epub 2013 Apr 5. J Nucl Med. 2013. PMID: 23564760 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page